Summary: For patients with severe aortic stenosis and cardiac symptoms who are at estimated to be at intermediate risk for surgical complications, transcatheter aortic-valve replacement (TAVR) may provide the same reduction in the 2-year risk of death or disabling stroke as surgical aortic valve replacement, with shorter duration of ICU stay and hospital admission. (However, the relative rates of other outcomes and adverse effects between TAVR and surgical AVR also require careful consideration).

http://www.ncbi.nlm.nih.gov/m/pubmed/27040324/

Strength of Recommendation = B

Advertisements